Amber Nocek
Physician Assistant · N Tonawanda, NYNPI 1730178088
Payments from drug & device makers
Across 191 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$708
- AstraZeneca$675
- Lilly USA, LLC$620
- Novo Nordisk$427
- Exact Sciences$182
- GSK$155
- plus $677 from 14 others
What the payments were for
- Food & beverage$3,443100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 34 | $708 |
| AstraZeneca | 36 | $675 |
| Lilly USA, LLC | 35 | $620 |
| Novo Nordisk | 30 | $427 |
| Exact Sciences | 9 | $182 |
| GSK | 8 | $155 |
| Pfizer | 6 | $124 |
| E.r. Squibb & Sons, L.L.C. | 7 | $108 |
| Amgen | 4 | $78 |
| Astellas Pharma US Inc | 4 | $74 |
| Bayer | 5 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Novartis | 2 | $38 |
| Abbott | 2 | $34 |
| Merck | 1 | $20 |
| Verona Pharma, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,443 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $96,824 |
| JardianceEmpagliflozin | 45 | $44,202 |
| JanuviaSitagliptin Phosphate | 30 | $40,322 |
| TrulicityDulaglutide | 25 | $22,935 |
| OzempicSemaglutide | 19 | $18,436 |
| MounjaroTirzepatide | 17 | $17,627 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $15,523 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $10,425 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $8,972 |
| XareltoRivaroxaban | 12 | $8,871 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $7,657 |
| Rosuvastatin Calcium | 246 | $5,554 |
| Levothyroxine Sodium | 256 | $4,356 |
| Atorvastatin Calcium | 320 | $4,156 |
| Ezetimibe | 47 | $4,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $96,824101 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $708 | $54,62762 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $620 | $40,56242 claims |
| MerckJanuvia | $20 | $40,32230 claims |
| Novo NordiskOzempic | $427 | $18,43619 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $675 | $12,91029 claims |
| Johnson & JohnsonXarelto | $18 | $8,87112 claims |
| GSKTrelegy Ellipta | $155 | $7,65713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in N Tonawanda
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.